The Australia animal health market size reached USD 779.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,001.6 Million by 2033, exhibiting a growth rate (CAGR) of 2.80% during 2025-2033. The market is driven by increased pet ownership, growing demand for livestock disease management, biosecurity regulations, veterinary technological advancements, and rising awareness of zoonotic diseases. Government initiatives, export-focused livestock industries, and evolving consumer preferences for high-quality animal-derived products further contribute to market growth.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 779.8 Million |
Market Forecast in 2033 | USD 1,001.6 Million |
Market Growth Rate 2025-2033 | 2.80% |
Rise in Companion Animal Therapeutics and Preventive Care
Australia has experienced a significant increase in pet ownership, with pet parents investing more in veterinary services, diagnostics, and wellness products. This shift has accelerated the development and availability of companion animal therapeutics, including targeted medications for chronic conditions, parasite control, and advanced diagnostic tools. For instance, in August 2024, Animal Medicines Australia highlighted a concerning rise in parasite cases, including fleas, ticks, and mod worms, posing year-round health threats to pets across the country. To support pet owners, AMA released educational materials, including a set of frequently asked questions, aimed at raising awareness about parasite control and promoting proactive protection strategies for companion animals. Preventive care, including annual health screenings and vaccinations, is becoming a routine expectation among Australian pet owners. Clinics are increasingly offering wellness plans and bundled services, responding to consumer demand for comprehensive and accessible animal healthcare. Additionally, the growth of pet insurance adoption is making high-cost treatments more financially viable, encouraging investment in long-term animal health. The trend highlights a shift from reactive to preventive care, expanding revenue opportunities across veterinary service providers and pharmaceutical companies.
Digitalization and Telehealth Integration in Veterinary Services
The digital transformation of the animal health sector in Australia is reshaping service delivery models. Veterinary telehealth has gained traction, offering remote consultations, prescription renewals, and post-operative follow-ups through secure platforms. This is particularly beneficial in rural and underserved areas where veterinary access has traditionally been limited. Digital platforms also facilitate pet health monitoring through wearables and app-based record systems, enabling real-time tracking of vitals and behavioral changes. Clinics are increasingly investing in digital practice management software to streamline operations, manage patient data, and enhance client engagement. These innovations not only improve efficiency but also align with changing consumer expectations around convenience and technology-enabled services. The integration of digital tools into animal healthcare is likely to continue expanding as part of broader health system modernization. For instance, in March 2025, One Health Epi Consulting launched "Animal Disease Insights," a free online dashboard for global animal disease data. It consolidates trends, country-specific outbreaks, and news, aiding professionals in disease surveillance and management. Developed without external funding, it aims for evidence-based decisions. Future plans include integrating social media data for real-time insights, enhancing public health responses.
Biosecurity and Livestock Disease Control Initiatives
Australia’s economic reliance on livestock exports places a strong emphasis on biosecurity and proactive disease management. The government, in collaboration with industry stakeholders, has strengthened surveillance systems and response protocols to protect against outbreaks such as foot-and-mouth disease or avian influenza. For instance, in October 2024, Animal Medicines Australia welcomed the Australian Government’s allocation of an additional AUD 95 Million to strengthen preparedness for high pathogenicity avian influenza (HPAI) H5N1. The investment is directed toward enhancing national biosecurity response systems, surveillance, scientific infrastructure, and vaccine acquisition for vulnerable captive bird species. The initiative is intended to safeguard agriculture and native wildlife from potential outbreaks. The animal health sector was recognized for its contribution to bird welfare and its alignment with government priorities through focused investments in disease response planning. Additionally, the livestock industry is increasing investment in vaccines, antimicrobial alternatives, and herd health analytics to minimize productivity losses and meet global trade standards. Heightened public and political focus on biosecurity is also encouraging innovation in diagnostic tools and early detection platforms. These efforts are reinforcing Australia’s reputation for maintaining high animal health standards, crucial for sustaining export competitiveness and market access.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region/country level for 2025-2033. Our report has categorized the market based on animal type and product type.
Animal Type Insights:
The report has provided a detailed breakup and analysis of the market based on the animal type. This includes commercial and companion.
Product Type Insights:
A detailed breakup and analysis of the market based on the product type have also been provided in the report. This includes pharmaceuticals, biologicals, medicinal feed additives, and diagnostics.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, and Western Australia.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Animal Types Covered | Commercial, Companion |
Product Types Covered | Pharmaceuticals, Biologicals, Medicinal Feed Additives, Diagnostics |
Regions Covered | Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, Western Australia |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |